PeriOperative ISchemic Evaluation-3 Trial

Summary

PeriOperative ISchemic Evaluation-3 Trial is a clinical trial^[1].

Key Facts

• PeriOperative ISchemic Evaluation-3 Trial is located in Hong Kong^[2].
• PeriOperative ISchemic Evaluation-3 Trial is in the country of Australia^[3].
• PeriOperative ISchemic Evaluation-3 Trial is in the country of Austria^[4].
• PeriOperative ISchemic Evaluation-3 Trial is in the country of Belgium^[5].
• PeriOperative ISchemic Evaluation-3 Trial is in the country of Brazil^[6].
• PeriOperative ISchemic Evaluation-3 Trial is in the country of Canada^[7].
• PeriOperative ISchemic Evaluation-3 Trial is in the country of Chile^[8].
• PeriOperative ISchemic Evaluation-3 Trial's instance of is recorded as clinical trial^[9].
• PeriOperative ISchemic Evaluation-3 Trial's start time is recorded as +2018-07-30T00:00:00Z^[10].
• PeriOperative ISchemic Evaluation-3 Trial's end time is recorded as +2020-07-31T00:00:00Z^[11].
• PeriOperative ISchemic Evaluation-3 Trial's sponsor is recorded as Population Health Research Institute^[12].
• PeriOperative ISchemic Evaluation-3 Trial's main subject is recorded as thrombosis^[13].
• PeriOperative ISchemic Evaluation-3 Trial's number of participants is recorded as {'unit': '1', 'amount': '+10000'}^[14].
• PeriOperative ISchemic Evaluation-3 Trial's title is recorded as PeriOperative ISchemic Evaluation-3 Trial^[15].
• PeriOperative ISchemic Evaluation-3 Trial's short name is recorded as POISE-3^[16].
• PeriOperative ISchemic Evaluation-3 Trial's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+45'}^[17].
• PeriOperative ISchemic Evaluation-3 Trial's ClinicalTrials.gov ID is recorded as NCT03505723^[18].
• PeriOperative ISchemic Evaluation-3 Trial's research intervention is recorded as tranexamic acid^[19].
• PeriOperative ISchemic Evaluation-3 Trial's clinical trial phase is recorded as phase III clinical trial^[20].
• PeriOperative ISchemic Evaluation-3 Trial's research site is recorded as Yale University^[21].
• PeriOperative ISchemic Evaluation-3 Trial's research site is recorded as Columbia University^[22].
• PeriOperative ISchemic Evaluation-3 Trial's research site is recorded as Wake Forest University^[23].
• PeriOperative ISchemic Evaluation-3 Trial's research site is recorded as Oregon Health and Science University^[24].
• PeriOperative ISchemic Evaluation-3 Trial's research site is recorded as Royal Hobart Hospital^[25].
• PeriOperative ISchemic Evaluation-3 Trial's research site is recorded as Westmead Hospital^[26].